Water Summary Update, April 24, 2014, No. 34

A snapshot of water resource trends prepared by the Iowa DNR in collaboration with the Iowa Department of Agriculture and Land Stewardship, the U.S. Geological Survey, and The Iowa Homeland Security and Emergency Management Department.

CIRAS News, Winter 2000, Vol. 34, no. 2

CIRAS is to enhance the performance of Iowa industry, and associated entities, through education and technology-based services. This newsletter holds information regarding these services.

Soil Survey of Iowa. Report no. 34, Boone County soils, 1924

This report contains a general colored soil map of Boone County and information on the county's soil physiology, drainage and fertility. It also includes information on field experiments, rotation of crops, prevention of erosion, soil types and other vital soil information in Boone County.

Iowa Board of Nursing Newsletter, February, March, April 2015 Vol. 34, no. 1

Newsletter produced by the Iowa Board of Nursing for nurses to keep them informed to CE classes, renewals, board meetings, etc. Produced 4 times a year. Also known as Nursing Newsletter.

Instruction sur le sarrasin . Publiée par la Commission d'agriculture et des arts. 10 prairial, an troisième... Insérée dans la Feuille du cultivateur, N° 34

Mécénat texte imprimé : Cet ouvrage a été numérisé grâce à Bazi à la mémoire de son père

Dysmegakaryopoiesis predicting response to therapy in acute myeloid leukaemia. A histologic and clinical study

With standard induction therapy between 50 to 85% of patients with Acute Myeloid Leukaemia (AML) achieve Complete Remission (CR). We investigated whether any morphological feature of bone marrow (BM) plastic embedded biopsies could predict failure of therapy. We reviewed BM plastic embedded biopsies from 54 adult patients presenting with untreated AML. The main histologic parameters analysed were cellularity, dysmegakaryopoiesis (DysM), percentage of marrow blasts and fibrosis. CR was obtained in 34 of 49 treated patients (69%). The rate of CR was significantly lower in the group of patients presenting with DysM: CR was achieved in 54% of the 28 treated patients with DysM and in 90% of the 21 treated patients without DysM (p less than 0.02). Patients with DysM had a significantly lower blood count and bone marrow blasts at presentation. Median age was not significantly different in the 2 groups. Cellularity and fibrosis were not predictive. DysM may be the hallmark of an AML subgroup with distinct clinical behaviour and lower rate of CR with conventional therapy. DysM should be carefully looked for on BM marrow biopsies and aspirate from AML patients at diagnosis.